APA (7th ed.) Citation

Lu, K., Li, X., Tian, H., Tian, T., Wu, A., Zhang, J., & Zhu, H. (2026). Monitoring Overall Survival in Phase 3 Indolent Cancers: An Extended Framework and an Example. Statistics in Biopharmaceutical Research, 18(2), 221. https://doi.org/10.1080/19466315.2025.2565155

Chicago Style (17th ed.) Citation

Lu, Kaifeng, Xiaoyun Li, Hong Tian, Tian Tian, Alan Wu, Jun Zhang, and Hongjie Zhu. "Monitoring Overall Survival in Phase 3 Indolent Cancers: An Extended Framework and an Example." Statistics in Biopharmaceutical Research 18, no. 2 (2026): 221. https://doi.org/10.1080/19466315.2025.2565155.

MLA (9th ed.) Citation

Lu, Kaifeng, et al. "Monitoring Overall Survival in Phase 3 Indolent Cancers: An Extended Framework and an Example." Statistics in Biopharmaceutical Research, vol. 18, no. 2, 2026, p. 221, https://doi.org/10.1080/19466315.2025.2565155.